Cargando…
Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort
BACKGROUND: There are limited data on the outcomes of rechallenge with anti-tuberculosis therapy (ATT) following anti-tuberculosis drug-induced liver injury (AT-DILI) in a high HIV prevalence setting. OBJECTIVES: To describe the outcomes of rechallenge with first-line ATT. METHOD: Hospitalised parti...
Autores principales: | Moosa, Muhammed Shiraz, Maartens, Gary, Gunter, Hannah, Allie, Shaazia, Chughlay, Mohamed F., Setshedi, Mashiko, Wasserman, Sean, Stead, David F., Cohen, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257779/ https://www.ncbi.nlm.nih.gov/pubmed/35923608 http://dx.doi.org/10.4102/sajhivmed.v23i1.1376 |
Ejemplares similares
-
Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023) -
The impact of Helicobacter pylori and intestinal helminth infections on gastric adenocarcinoma and inflammatory bowel disease in Sub-Saharan Africa
por: Setshedi, Mashiko, et al.
Publicado: (2022) -
Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements
por: Wilson, Douglas, et al.
Publicado: (2018) -
Helicobacter pylori Infection: Antibiotic Resistance and Solutions for Effective Management in Africa
por: Setshedi, Mashiko, et al.
Publicado: (2023) -
Melanoma: BRAFi Rechallenge
por: Kosmidis, Christoforos S., et al.
Publicado: (2023)